Names | |
---|---|
IUPAC name -11-hydroxy-5-methyl-2-oxiran-2-yl]-4,7,12-trioxonaphthochromen-10-yl]-2,4-dimethyloxan-3-yl] acetate | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
ChemSpider | |
PubChem CID | |
CompTox Dashboard (EPA) | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C43H52N2O11 |
Molar mass | 772.892 g·mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Infobox references |
Pluramycin A is an antibiotic/anticancer compound that inhibits nucleic acid biosynthesis. The pluramycin family of natural products are an important group of complex C-aryl glycoside antibiotics that possess the tetracyclic 4H-anthrapyran-4,7,12-trione moiety A–D as an aromatic core. The D-ring is adorned with two deoxyaminosugars that are appended by C-aryl glycosidic linkages. The E-ring sugar is angolosamine, a carbohydrate that is also found in the antibiotic angolamycin. The F-ring sugar is the N,N-dimethyl derivative of vancosamine, which is the sugar found in the glycopeptide antibiotic vancomycin.
These compounds exhibit in vitro antitumor activity by DNA alkylation, where the two proximal amino sugars, D-angolosamine and N,N-dimethyl-L-vancosamine, play a key role in sequence recognition in intercalation of the tetracyclic chromophore.
References
- Nagai, K.; Yamaki, H.; Tanaka, N.; Umezwa, H. (1967). "Inhibition by pluramycin a of nucleic acid biosynthesis". Journal of Biochemistry. 62 (3): 321–7. PMID 4869973.
This article about an organic compound is a stub. You can help Misplaced Pages by expanding it. |